Cipla Ltd. Financials

NSE BSE

15:57 Jul 30

Cipla Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1559.40

-14.60 (-0.93%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1559.40

-14.60 (-0.93%)
15:57 Jul 30

Quality

59/100
High Financial Strength

Valuation

44/100
Mid Valuation

Technical

63/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	21763.34	22753.12	25774.09	27547.62	27811.15
Operating Expenses +	17210.56	17726.15	19483.04	20419.72	20620.91
Raw Material	9220.29	8348.28	8756.54	9261.09	9414.57
Increase Decrease in Cost	-724.69	-96	63.03	-332.1	-507.75
Other Manufacturing Expense	0	0	640.62	667.72	0
Employee Cost	3529.91	3830.08	4310.04	4832.83	4950.9
Miscellaneous Expenses	12559.37	11301.11	12784.87	13693.16	6763.19
Operating Profit	4552.78	5026.97	6291.05	7127.9	7190.24
Other Income	280.91	475.45	746.57	861.87	960.24
Depreciation	1051.95	1172.11	1051.02	1106.95	1112.99
Interest	106.35	109.54	89.88	62.01	58.11
Profit before tax and exceptio..	3675.39	4220.77	5896.72	6820.81	6979.38
Exceptional Items	-182.12	-182.42	-194.82	0	0
PBT	3493.27	4038.35	5701.9	6820.81	6979.38
Provision for Taxation	933.8	1202.86	1546.59	1529.76	1572.57
Net Profit	2559.47	2835.49	4155.31	5291.05	5406.81
NET Profit after MI	2516.75	2801.91	4121.55	5272.52	5392.5
EPS	31.17	34.69	51.01	65.29	66.94
Operating Profit Margin (%)	20.92	22.09	24.41	25.87	25.85
Net Profit Margin (%)	11.56	12.31	15.99	19.14	19.39

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	29.20	29.20	29.20	30.90	30.90
FII	25.20	26.30	26.60	28.80	27.80
MF	20.40	20.50	20.50	17.50	17.60
Others	8.90	7.60	7.30	6.70	7.40

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: